{
    "Company Name": "Emcure Pharma IPO",
    "IPO_Date": "July 3, 2024 to July 5, 2024",
    "Listing_Date": "Wednesday, July 10, 2024",
    "Face_Value": "10 per share",
    "Price_Band": "960 to 1008 per share",
    "Lot_Size": "14 Shares",
    "Total_Issue_Size": "19,365,346 shares (aggregating up to 1,952.03 Cr)",
    "Fresh_Issue": "7,936,507 shares (aggregating up to 800.00 Cr)",
    "Offer_for_Sale": "11,428,839 shares of 10 (aggregating up to 1,152.03 Cr)",
    "Employee_Discount": "Rs 90 per share",
    "Issue_Type": "Book Built Issue IPO",
    "Listing_At": "BSE, NSE",
    "Share_holding_pre_issue": "180,852,116",
    "Share_holding_post_issue": "188,788,623",
    "Investor_Category": "Maximum Allottees",
    "Anchor_Investor_Shares_Offered": "NA",
    "QIB_Shares_Offered": "NA",
    "NII_(HNI)_Shares_Offered": "",
    "bNII_>_₹10L": "9,174",
    "sNII_<_₹10L": "4,587",
    "Retail_Shares_Offered": "481,654",
    "Employee_Shares_Offered": "NA",
    "Total_Shares_Offered": "",
    "Bid_Date": "July 2, 2024",
    "Shares_Offered": "5,779,850",
    "Anchor_Portion_Size_(In_Cr.)": "582.61",
    "Anchor_lock-in_period_end_date_for_50%_shares_(30_Days)": "August 7, 2024",
    "Anchor_lock-in_period_end_date_for_remaining_shares_(90_Days)": "October 6, 2024",
    "IPO_Open_Date": "Wednesday, July 3, 2024",
    "IPO_Close_Date": "Friday, July 5, 2024",
    "Basis_of_Allotment": "Monday, July 8, 2024",
    "Initiation_of_Refunds": "Tuesday, July 9, 2024",
    "Credit_of_Shares_to_Demat": "Tuesday, July 9, 2024",
    "Cut-off_time_for_UPI_mandate_confirmation": "5 PM on July 5, 2024",
    "Application": "Amount",
    "Retail_(Min)": "14,112",
    "Retail_(Max)": "197,568",
    "S-HNI_(Min)": "211,680",
    "S-HNI_(Max)": "987,840",
    "B-HNI_(Min)": "1,001,952",
    "Lot_Size_Calculator": "Lot Size Calculator",
    "Share_Holding_Pre_Issue": "98.90%",
    "Share_Holding_Post_Issue": "78.24%",
    "KPI": "Values",
    "ROE": "16.90%",
    "ROCE": "19.37%",
    "Debt/Equity": "0.67",
    "RoNW": "16.87%",
    "P/BV": "6.18",
    "": "Post IPO",
    "EPS_(Rs)": "27.95",
    "P/E_(x)": "36.07",
    "Review_By": "Avoid",
    "Brokers": "0",
    "Members": "0"
}